Wednesday−Thursday, July 8–9
CME/CE Credits
8–9am ET
CME/CE Accredited Session
New Horizons in Dyslipidemia 2026
9:10–10:10am ET
CME/CE Accredited Session
Incretin Therapies: In Whom, Why, and How
10:20–11:05am ET
Non-CME Industry Theater
11:15am–12:15pm ET
CME/CE Accredited Session
Pulmonary Embolism: New Definitions, New Guidelines
12:25–1:25pm ET
CME/CE Accredited Session
Safer Anticoagulation on the Horizon: Will Factor XI Inhibitors Reduce Bleeding Risk?
1:35–2:20pm ET
Non-CME Industry Theater
Redemplo® (plozasiran): A Treatment to Lower Triglycerides for Adults With Familial Chylomicronemia Syndrome (FCS)
Sponsored by Arrowhead Pharmaceuticals
On DemandNon-CME Industry Theater
Rethinking Hyperkalemia Management in Patients on RAASi Therapy
Sponsored by AstraZeneca
2:30–3:30pm ET
CME/CE Accredited Session
Navigating the Heart-Kidney Interface
3:40–4:40pm ET
CME/CE Accredited Session
Atrial Fibrillation: Do New Technologies Reframe the Rhythm vs. Rate Control Debate?
4:55–5:40pm ET
Non-CME Industry Theater
Essential Heart Failure Care: Insights Into Heart Failure
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
8–9am ET
CME/CE Accredited Session
Inflammation in Atherosclerosis: Lessons and Therapeutic Implications
9:10–10:10am ET
CME/CE Accredited Session
Hidden Cardiovascular Risks in Primary Care: Lipoprotein(a), CAC Scoring, and Emerging Biomarkers
10:20–11:05am ET
Non-CME Industry Theater
Discovering hidden dangers: The critical link between CKD, albuminuria, and cardiovascular risk
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
11:15am–12:15pm ET
CME/CE Accredited Session
Vaccination as Cardiovascular Risk Reduction
12:25–1:10pm ET
Non-CME Industry Theater
Customer Help Information
We are here to help. If you need assistance, please contact us through your preferred channel:
Phone: 877-477-4633
(Monday-Thursday, 9am-5pm ET, Friday 9am-2pm ET).
Email: support@pri-med.com